The global detergent viral inactivation product market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for blood and blood products, cellular and gene therapy products, stem cell products, tissue and tissue products, vaccines and therapeutics. The increasing demand for these products has led to an increase in the number of hospitals that are using viral inactivation systems for their operations. Viral inactivation systems are used by hospitals as they help reduce the risk of infection among patients who have undergone surgery or other medical procedures.
-The global detergent viral inactivation product market is expected to grow at a CAGR of 4.5% from 2017 to 2025.
-The global detergent viral inactivation product market is expected to reach USD 1.2 billion by 2025, from USD 0.8 billion in 2017.
-Increasing awareness about the benefits of using disinfectants and sanitizers for personal hygiene purposes will drive the demand for these products over the forecast period.
Industry Growth Insights published a new data on “Detergent Viral Inactivation Product Market”. The research report is titled “Detergent Viral Inactivation Product Market research by Types (Kits and Reagents, Services, Viral Inactivation Systems and Accessories), By Applications (Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products, Vaccines and Therapeutics), By Players/Companies Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), WuXi PharmaTech (Cayman) Inc. (China)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Detergent Viral Inactivation Product Market Research Report
By Type
Kits and Reagents, Services, Viral Inactivation Systems and Accessories
By Application
Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products, Vaccines and Therapeutics
By Companies
Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), WuXi PharmaTech (Cayman) Inc. (China)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Detergent Viral Inactivation Product Market Report Segments:
The global Detergent Viral Inactivation Product market is segmented on the basis of:
Types
Kits and Reagents, Services, Viral Inactivation Systems and Accessories
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products, Vaccines and Therapeutics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Clean Cells (France)
- Charles River Laboratories International, Inc. (U.S.)
- Danaher Corporation (U.S.)
- Merck KGaA (Germany)
- Parker Hannifin (U.S.)
- Rad Source Technologies (U.S.)
- Sartorius AG (Germany)
- SGS S.A. (Switzerland)
- Texcell, Inc. (France)
- Viral Inactivated Plasma Systems SA (Switzerland)
- WuXi PharmaTech (Cayman) Inc. (China)
Highlights of The Detergent Viral Inactivation Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kits and Reagents
- Services
- Viral Inactivation Systems and Accessories
- By Application:
- Blood & Blood Products
- Cellular & Gene Therapy Products
- Stem Cell Products
- Tissue & Tissue Products
- Vaccines and Therapeutics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Detergent Viral Inactivation Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Detergent viral inactivation product (DVP) is a detergent-based disinfectant used to inactivate viruses. It is most commonly used to clean surfaces that may be contaminated with viruses, such as computer keyboards and monitors.
Some of the major companies in the detergent viral inactivation product market are Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), WuXi PharmaTech (Cayman) Inc. (China).
The detergent viral inactivation product market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Detergent Viral Inactivation Product Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Detergent Viral Inactivation Product Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Detergent Viral Inactivation Product Market - Supply Chain
4.5. Global Detergent Viral Inactivation Product Market Forecast
4.5.1. Detergent Viral Inactivation Product Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Detergent Viral Inactivation Product Market Size (000 Units) and Y-o-Y Growth
4.5.3. Detergent Viral Inactivation Product Market Absolute $ Opportunity
5. Global Detergent Viral Inactivation Product Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Detergent Viral Inactivation Product Market Size and Volume Forecast by Type
5.3.1. Kits and Reagents
5.3.2. Services
5.3.3. Viral Inactivation Systems and Accessories
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Detergent Viral Inactivation Product Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Detergent Viral Inactivation Product Market Size and Volume Forecast by Application
6.3.1. Blood & Blood Products
6.3.2. Cellular & Gene Therapy Products
6.3.3. Stem Cell Products
6.3.4. Tissue & Tissue Products
6.3.5. Vaccines and Therapeutics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Detergent Viral Inactivation Product Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Detergent Viral Inactivation Product Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Detergent Viral Inactivation Product Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Detergent Viral Inactivation Product Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Detergent Viral Inactivation Product Demand Share Forecast, 2019-2026
9. North America Detergent Viral Inactivation Product Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Detergent Viral Inactivation Product Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Detergent Viral Inactivation Product Market Size and Volume Forecast by Application
9.4.1. Blood & Blood Products
9.4.2. Cellular & Gene Therapy Products
9.4.3. Stem Cell Products
9.4.4. Tissue & Tissue Products
9.4.5. Vaccines and Therapeutics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Detergent Viral Inactivation Product Market Size and Volume Forecast by Type
9.7.1. Kits and Reagents
9.7.2. Services
9.7.3. Viral Inactivation Systems and Accessories
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Detergent Viral Inactivation Product Demand Share Forecast, 2019-2026
10. Latin America Detergent Viral Inactivation Product Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Detergent Viral Inactivation Product Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Detergent Viral Inactivation Product Market Size and Volume Forecast by Application
10.4.1. Blood & Blood Products
10.4.2. Cellular & Gene Therapy Products
10.4.3. Stem Cell Products
10.4.4. Tissue & Tissue Products
10.4.5. Vaccines and Therapeutics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Detergent Viral Inactivation Product Market Size and Volume Forecast by Type
10.7.1. Kits and Reagents
10.7.2. Services
10.7.3. Viral Inactivation Systems and Accessories
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Detergent Viral Inactivation Product Demand Share Forecast, 2019-2026
11. Europe Detergent Viral Inactivation Product Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Detergent Viral Inactivation Product Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Detergent Viral Inactivation Product Market Size and Volume Forecast by Application
11.4.1. Blood & Blood Products
11.4.2. Cellular & Gene Therapy Products
11.4.3. Stem Cell Products
11.4.4. Tissue & Tissue Products
11.4.5. Vaccines and Therapeutics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Detergent Viral Inactivation Product Market Size and Volume Forecast by Type
11.7.1. Kis and Reagents
11.7.2. Services
11.7.3. Viral Inactivation Systems and Accessories
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Detergent Viral Inactivation Product Demand Share, 2019-2026
12. Asia Pacific Detergent Viral Inactivation Product Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Detergent Viral Inactivation Product Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Detergent Viral Inactivation Product Market Size and Volume Forecast by Application
12.4.1. Blood & Blood Products
12.4.2. Cellular & Gene Therapy Products
12.4.3. Stem Cell Products
12.4.4. Tissue & Tissue Products
12.4.5. Vaccines and Therapeutics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Detergent Viral Inactivation Product Market Size and Volume Forecast by Type
12.7.1. Kits and Reagents
12.7.2. Services
12.7.3. Viral Inactivation Systems and Accessories
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Detergent Viral Inactivation Product Demand Share, 2019-2026
13. Middle East & Africa Detergent Viral Inactivation Product Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Detergent Viral Inactivation Product Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Detergent Viral Inactivation Product Market Size and Volume Forecast by Application
13.4.1. Blood & Blood Products
13.4.2. Cellular & Gene Therapy Products
13.4.3. Stem Cell Products
13.4.4. Tissue & Tissue Products
13.4.5. Vaccines and Therapeutics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Detergent Viral Inactivation Product Market Size and Volume Forecast by Type
13.7.1. Kits and Reagents
13.7.2. Services
13.7.3. Viral Inactivation Systems and Accessories
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Detergent Viral Inactivation Product Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Detergent Viral Inactivation Product Market: Market Share Analysis
14.2. Detergent Viral Inactivation Product Distributors and Customers
14.3. Detergent Viral Inactivation Product Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Clean Cells (France)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Charles River Laboratories International, Inc. (U.S.)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher Corporation (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck KGaA (Germany)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Parker Hannifin (U.S.)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Rad Source Technologies (U.S.)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sartorius AG (Germany)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SGS S.A. (Switzerland)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Texcell, Inc. (France)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Viral Inactivated Plasma Systems SA (Switzerland)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. WuXi PharmaTech (Cayman) Inc. (China)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
